Parvin Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$379K Sell
4,850
-150
-3% -$12.1K 0.3% 91
2026
Q1
$433K Sell
5,000
-150
-3% -$14.4K 0.31% 89
2025
Q4
$495K Buy
5,150
+250
+5% +$24.3K 0.39% 76
2025
Q3
$467K Buy
4,900
+50
+1% +$4.6K 0.41% 74
2025
Q2
$423K Sell
4,850
-275
-5% -$23.3K 0.42% 78
2025
Q1
$461K Sell
5,125
-8,045
-61% -$720K 0.5% 65
2024
Q4
$1.05M Buy
+13,170
New +$1.14M 1.11% 22

Other funds holding MDT

Parvin Asset Management's MDT Position: Q2 2026 in Review

Parvin Asset Management reduced its Medtronic (MDT) stake by 3% in Q2 2026, selling an estimated $12.1K and leaving 4,850 shares worth $379K. The position accounts for 0.3% of the portfolio, ranked #91.

Parvin Asset Management first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.05M in Q4 2024. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Parvin Asset Management held 4,850 shares of Medtronic worth $379K as of Q2 2026.
  • Parvin Asset Management sold 150 Medtronic shares in Q2 2026, an estimated $12.1K.
  • Medtronic made up 0.3% of Parvin Asset Management's portfolio in Q2 2026, its #91 holding.
  • Parvin Asset Management first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Parvin Asset Management's Medtronic position peaked at $1.05M in Q4 2024.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Parvin Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.